Ellen ‘t Hoen
Ellen ‘t Hoen, LLM is a lawyer and public health advocate with over 30 years of experience working on pharmaceutical and intellectual property policies.
From 1999 until 2009 she was the director of policy for Médecins sans Frontières’ Campaign for Access to Essential Medicines. In 2009 she joined UNITAID in Geneva to set up the Medicines Patent Pool of which she was the executive director until 2012.
She is a member of various advisory committees including the WHO Expert Advisory Panel on Drug Policies and Management and the Advisory Board of Universities Allied for Essential Medicines (UAEM). She is the rapporteur of the Global Health Law Committee of the International Law Association and member of the Editorial Board of the Journal of Public Health Policy.
Since 2012 she works as an independent researcher and consultant in medicines law and policy for a variety of international organisations. Early 2016 she joined the Global Health Unit of the University Medical Centre at the University of Groningen where she does research on intellectual property and medicines law and policies.
In 2005, 2006, 2010 and 2011 she was listed as one of the 50 most influential people in intellectual property by the journal Managing Intellectual Property.
She has published widely and is the author of the book The Global Politics of Pharmaceutical Monopoly Power, Drug patents, access, innovation and the application of the WTO Doha Declaration on TRIPS and Public Health” (2009).
Her new book Private Patents and Public Health: Changing intellectual property rules for access to medicines will come out in the spring of 2016.
Selected publications of interest:
Gray AL, Wirtz VJ, ‘t Hoen EF, Reich MR, Hogerzeil HV. Essential medicines are still essential. The Lancet. 2015 Oct 24;386(10004):1601-3.
‘t Hoen E, Pascual F. Viewpoint: Counterfeit medicines and substandard medicines: Different problems requiring different solutions. Journal of Public Health Policy. 2015 Nov 1;36(4):384-9.
‘t Hoen E, Inside Views: Why The Request By Least Developed Countries for An Extension of The Transitional Period for granting and enforcing medicines patents needs to be supported. IP-Watch, February (2015).
‘t Hoen E., Access to Cancer Treatment. A study of medicine pricing issues with recommendations for improving access to cancer medication. Oxfam, February (2015).
‘t Hoen EFM, Hogerzeil HV, Quick JD, Sillo HB. A quiet revolution in global public health: The World Health Organization’s Prequalification of Medicines Programme. Journal of Public Health Policy. 2014 May 1;35(2):137-61.
‘t Hoen E. A victory for global public health in the Indian Supreme Court. Journal of Public Health Policy. 2013 Aug 27;34(3):370-4.
‘t Hoen E, Passereli C, The role of Intellectual Property Rights in treatment access: Challenges and solutions. Curr Opin HIV AIDS 2013, 8:70–74. DOI:10.1097/COH.0b013e32835b6e5a